Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.

09/16/2026, 1:00 PM • GlobeNewswire

Telepsychiatry Market Size to Surge to USD 70.95 Billion by 2035 at a CAGR of 20.81% - SNS Insider

The global telepsychiatry market is projected to grow from USD 10.71 billion in 2025 to USD 70.95 billion by 2035 at a CAGR of 20.81%, driven by psychiatrist shortages, reimbursement reforms, and increased adoption of virtual mental healthcare. North America leads with 32% market share, while Asia Pacific shows the fastest growth. Key trends include AI-driven patient matching, employer-sponsored programs, and integration with primary care.

09/14/2026, 8:30 PM • GlobeNewswire

Enterprise Imaging Solutions Market Set to Hit USD 6.69 Billion by 2035, Growing at a CAGR of 11.18% - SNS Insider

The Enterprise Imaging Solutions Market is projected to grow from USD 2.32 billion in 2025 to USD 6.69 billion by 2035, with a CAGR of 11.18%. Growth is driven by cloud-native platforms, AI-driven workflows, and vendor consolidation. North America leads with 44% market share, while Asia-Pacific shows the fastest growth at 15% CAGR. Software remains the largest component at 58% share, with cloud deployment and services as the fastest-growing segments.

09/10/2026, 8:30 PM • GlobeNewswire

1 No-Brainer ETF I'm Loading Up on in 2026 and Beyond

The Schwab U.S. Dividend Equity ETF (SCHD) is recommended as a core holding for long-term investors seeking diversified dividend income. With a 3% dividend yield (three times higher than S&P 500 ETFs), low 0.06% expense ratio, and exposure to stable sectors like healthcare and consumer staples, SCHD offers attractive passive income potential. The ETF has delivered 29% total returns year-to-date and is particularly suitable for tax-advantaged accounts like Roth IRAs.

09/08/2026, 2:37 PM • The Motley Fool

UnitedHealth Group Stock Is Up 39.4% in the Last 6 Months. How High Can It Go?

UnitedHealth Group (UNH) surged 39.4% over six months, driven by strong Q1 earnings and investor confidence in the company's turnaround efforts, including a $3 billion AI investment. However, the stock has pulled back since July due to concerns about rising healthcare costs from GLP-1 drugs and independent dispute resolutions. Trading at 18x estimated 2027 earnings, analysts remain bullish, viewing recent volatility as a potential buying opportunity if management's AI-driven strategy delivers expected mid-to-high teens earnings growth.

09/08/2026, 9:05 AM • The Motley Fool

Billionaire David Tepper Sold Every Single Share of UnitedHealth in Q2. Here's Whether He Made a Costly Mistake.

Billionaire hedge fund manager David Tepper sold all 90,000 shares of UnitedHealth in Q2 to concentrate on AI investments. While medical cost pressures from GLP-1 drugs and inflation are real concerns, the article argues Tepper may have made a mistake, as UnitedHealth is actively managing costs through AI automation, workflow improvements, and strategic GLP-1 coverage policies. The company's operating margins improved and earnings growth remains strong, suggesting it's adapting well to healthcare industry changes.

08/26/2026, 6:30 AM • The Motley Fool

The AI Honeymoon is Over: Momentum AI Austin 2026 Unveils Full C-Suite Agenda and Premier Sponsors to Drive Enterprise ROI

Reuters Events announced Momentum AI Austin 2026, an enterprise AI summit scheduled for September 24-25, 2026, bringing together over 500 senior leaders including CIOs, CTOs, and Chief AI Officers. The summit addresses the critical challenge of transitioning AI from pilot projects to scalable business execution, featuring keynotes on rising compute costs and adoption bottlenecks, with speakers including FTC Chairman Andrew Ferguson and executives from major corporations like Walmart, UnitedHealth Group, and Charles Schwab.

08/25/2026, 2:46 PM • GlobeNewswire

AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?

The article compares AbbVie and CVS Health as healthcare investment options in 2026. AbbVie, a biopharmaceutical company with a $438B market cap, is recommended as the better choice due to its focused growth trajectory, strong drug pipeline (Skyrizi and Rinvoq), and attractive dividend yield. CVS Health, a diversified healthcare provider with a $122B market cap managing 37 million medical members, is acknowledged as a turnaround story showing stabilization but is considered less compelling than AbbVie's growth prospects.

08/11/2026, 4:27 PM • The Motley Fool

This Buffett Oil Stock Is Quietly Outperforming Chevron Under Greg Abel. Is It Worth Buying Now?

Occidental Petroleum has surged 36% since Greg Abel became Berkshire Hathaway's CEO in January, outperforming Chevron and the S&P 500. The rally was driven by U.S.-Iran tensions and crude oil price spikes. However, recent muted performance raises questions about sustainability. Future gains depend heavily on another crude oil price surge, particularly when China replenishes its strategic reserves, making Oxy a more volatile bet compared to Chevron's more stable outlook.

08/11/2026, 3:05 PM • The Motley Fool

Worried About the Market? These Stocks Have a Track Record of Helping Investors Sleep at Night.

The article recommends three healthcare dividend growth stocks for investors seeking portfolio stability during market volatility: Johnson & Johnson (a Dividend King with 64 consecutive years of dividend increases), UnitedHealth Group (rebounding after recent challenges with a 2.26% yield), and McKesson (the largest U.S. pharmaceutical distributor with steady dividend growth). Healthcare is highlighted as a defensive sector due to non-discretionary spending patterns.

08/06/2026, 10:15 AM • The Motley Fool

[Latest] Global AI in Medical Coding Market Size/Share Worth USD 10.6 Billion by 2035 at a 13.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global AI in medical coding market is valued at USD 3 billion in 2025 and is expected to grow to USD 10.6 billion by 2035, expanding at a 13.5% CAGR. Key market players include 3M Company, Optum Inc., Nuance Communications Inc., Oracle Health, and others. The market growth is driven by increasing demand for automated code assignment, fraud detection, and compliance monitoring across healthcare providers and payers.

07/29/2026, 12:30 AM • GlobeNewswire

UnitedHealth Stock Has Rallied Big Since Berkshire Bailed. Did Warren Buffett and Greg Abel Blink Too Soon?

Berkshire Hathaway sold its UnitedHealth Group position in Q1 2026 at a loss after buying around $380/share in Q2 2025. The stock has since rebounded to $428, driven by improving profit margins as the company recovers from elevated medical loss ratios in 2025. UnitedHealth's medical care ratio is normalizing, and with strong secular tailwinds from healthcare inflation and potential earnings recovery to $25-30 billion, the stock appears undervalued at current levels.

07/28/2026, 7:30 PM • The Motley Fool

If I Were Starting My Portfolio From Scratch Today, This Is the First ETF I'd Buy

An experienced investor recommends the Schwab U.S. Dividend Equity ETF (SCHD) as the foundational holding for a new portfolio. The ETF focuses on high-yielding dividend-growth stocks and has delivered over 12% average annualized returns over multiple periods, outperforming pure growth stocks and high-yield stocks with lower volatility.

07/26/2026, 8:30 AM • The Motley Fool

This Dividend ETF Yields 3.2% and Is Beating the Nasdaq-100 This Year

The Schwab U.S. Dividend Equity ETF (SCHD) has returned approximately 20% in 2026, outperforming both the S&P 500 and Nasdaq-100. The $95 billion fund focuses on companies with at least 10 consecutive years of dividend payments and screens for quality fundamentals. Its concentration in healthcare and consumer staples has benefited from a market rotation away from expensive AI and software stocks, though the fund's long-term job is delivering growing income from durable businesses rather than outrunning growth indexes.

07/18/2026, 8:23 AM • The Motley Fool

Dow Jones Hangs On While Memory Chips Take Another Beating

The semiconductor sector continued its fourth consecutive day of losses after Taiwan Semiconductor raised capital expenditure forecasts to $60-64 billion, sparking investor concerns about profitability. Memory chip stocks like SK Hynix and Micron plummeted, dragging down the Nasdaq and S&P 500. The Dow remained relatively stable as healthcare stocks, particularly UnitedHealth and Abbott Laboratories, rallied on strong earnings, offsetting tech sector weakness.

07/16/2026, 1:03 PM • The Motley Fool